NCT06056024
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06056024
Title A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic-Arizona Phoenix Arizona 85054 United States Details
Yale Cancer Center New Haven Connecticut 06511 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
National Cancer Center Hospital East Chiba, Kashiwa 277-8577 Japan Details
Japanese Foundation for Cancer Research Tokyo, Koto-ku 135-8550 Japan Details
Seoul National University Bundang Hospital Seongnam 13620 South Korea Details
Seoul National University Hospital Seoul 03080 South Korea Details
Severance Hospital Seoul 03722 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Samsung Medical Center Seoul 135-710 South Korea Details
The Catholic University of Korea, Seoul St.Mary's Hospital Seoul 137-701 South Korea Details
Ajou University Hospital Suwon 16499 South Korea Details
NCKUH Tainan 704 Taiwan Details
National Taiwan University Hospital Taipei 100 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field